Home/Filings/4/0000899243-16-017254
4//SEC Filing

PROVECTUS BIOPHARMACEUTICALS, INC. 4

Accession 0000899243-16-017254

$PVCTCIK 0000315545operating

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 7:31 PM ET

Size

17.0 KB

Accession

0000899243-16-017254

Insider Transaction Report

Form 4
Period: 2016-03-29
Koe Jan
Director
Transactions
  • Exercise Out-of-Money

    Common Stock

    2016-03-29$1.25/sh+100,000$125,000786,300 total
  • Exercise Out-of-Money

    Common Stock Warrants (right to buy)

    2016-03-29100,0000 total
    Exercise: $1.25From: 2012-06-28Exp: 2016-04-15Common Stock (100,000 underlying)
  • Exercise Out-of-Money

    Common Stock Warrants (right to buy)

    2016-03-29100,0000 total
    Exercise: $1.25From: 2011-04-20Exp: 2016-04-20Common Stock (100,000 underlying)
  • Exercise Out-of-Money

    Common Stock

    2016-03-29$1.25/sh+100,000$125,000686,300 total
  • Exercise Out-of-Money

    Common Stock Warrants (right to buy)

    2016-03-29+100,000100,000 total
    Exercise: $0.85From: 2016-03-29Exp: 2020-06-19Common Stock (100,000 underlying)
  • Exercise Out-of-Money

    Common Stock Warrants (right to buy)

    2016-03-29+100,000100,000 total
    Exercise: $0.85From: 2016-03-29Exp: 2020-06-19Common Stock (100,000 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    150,000
Footnotes (1)
  • [F1]On March 29, 2016, the reporting person exercised an aggregate of 200,000 warrants pursuant to the Issuer's warrant exchange offer, at a discounted exercise price of $0.50 per share, which exercise consisted of: (i) an exercise of 100,000 shares pursuant to a warrant issued on June 28, 2012, with an original exercise price of $1.25 per share and (ii) an exercise of 100,000 shares pursuant to a warrant issued on September 20, 2013, with an original exercise price of $1.25 per share. Under the terms of the warrant exchange offer, holders received, in addition to the common stock acquired upon exercise of their existing warrants, an equal number of new warrants to purchase the same number of shares of the Issuer's common stock at an exercise price of $0.85 per share that will expire June 19, 2020.

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000315545

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:31 PM ET
Size
17.0 KB